Our highlighted selection of Covid-related Literature Reviews from the scientific press for January 2023.
Category
EAN News
-
-
EAN NewsResearchCOVID-19
COVID-19 Research Round-Up: Case Series/Case Reports – January 2023
January 17, 2023Our highlighted selection of recent Covid-related case series or case reports from the scientific press for January 2023. -
EAN NewsResearchCOVID-19
COVID-19 Research Round-Up: Cross-Sectional Case Control Studies – January 2023
January 17, 2023Our pick of COVID-19-related cross-sectional case control studies from the scientific press for January 2023. -
EAN NewsResident and Research FellowsEducation corner
13th Regional Teaching Course in Sub-Saharan Africa – Report
January 12, 2023The 13th EAN Regional Teaching Course took place in Douala, Cameroon on 20 October, a day prior to the 3rd AFAN (African Academy of Neurology) Congress. -
EAN NewsEAN Congress news
EAN launches new ‘Congress Spin-Off with Masterclasses’ event, with first edition in March
January 10, 2023The Congress Spin-Off with Masterclasses is a new EAN event that will gather smaller groups of participants, taking outstanding lectures from the previous EAN Annual Congress as a starting point for discussion in a number of masterclasses. -
EAN NewsTop ArticlesFeatured Slider
EAN gives preview of upcoming Strategic Research Agenda at European Parliament
January 1, 2023Under the auspices of the Czech Presidency of the Council of the European Union and with support from MEP Ondřej Knotek, The European Academy of Neurology (EAN) gathered a range of stakeholders at the European Parliament in Brussels on Thursday, December 8 to give them a glimpse of EAN’s forthcoming research agenda. -
Paper of the MonthEAN NewsFeatured Slider
Research Paper of the Month: Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT)
January 1, 2023Our paper of the month reports the results of the ENCHANTED 2/MT trial, performed in 44 Chinese hospitals to compare more intensive with less intensive blood pressure management after successful endovascular thrombectomy. -
Paper of the MonthEAN NewsCOVID-19Featured Slider
COVID-19 Paper of the Month: The decline in stroke hospitalization due to COVID-19 is unrelated to COVID-19 intensity
January 1, 2023Our authors of the month compared the occurrence of stroke, utilisation of recanalisation procedures, and demographic parameters during the pandemic period with data from the preceding year. -
EAN NewsResident and Research FellowsResearch
Impact of Burnout on Neurology Residents and Research Fellows in Europe
December 23, 2022This recent EAN-funded study investigates the prevalence of burnout profiles and their contributing factors in European neurology residents, junior neurologists, and research fellows. -
EAN NewsResearchCOVID-19
COVID-19 Research Round-Up: Meta-analyses/systematic reviews – December 2022
December 23, 2022Our highlighted selection of COVID-19-related meta-analyses and systemic reviews from the scientific press for December 2022. -
EAN NewsResearchCOVID-19
COVID-19 Research Round-Up: Cross-Sectional Case Control Studies – December 2022
December 23, 2022Our pick of COVID-19-related cross-sectional case control studies from the scientific press for December 2022. -
EAN President, Paul Boon, reflects on a busy and successful 2022 and wishes all EAN members and friends a joyful holiday season.
-
EAN NewsSurveys
Help EAN contribute towards the development of a European Pain Research strategy
December 5, 2022Researchers involved in pain science: fill out this survey to have your say on the priorities to be established within the EFIC Pain Research Strategy. -
Executive PageEAN NewsFeatured Slider
Executive Page: Submit, register, and join us for EAN 2023
December 5, 2022Abstract submission for our next annual congress is now open! EAN Programme Committee Chair, Prof. Ulf Kallweit shares the details on this and other latest news about EAN 2023. -
Paper of the MonthEAN NewsFeatured Slider
Research Paper of the Month: Lecanemab in Early Alzheimer’s Disease
December 5, 2022Our authors of the month report the results of a multicentre phase-3 clinical trial exploring efficacy and safety of Lecanemab in patients with early AD over a follow-up period of eighteen months.